BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Arbués A, Brees D, Chibout SD, Fox T, Kammüller M, Portevin D. TNF-α antagonists differentially induce TGF-β1-dependent resuscitation of dormant-like Mycobacterium tuberculosis. PLoS Pathog 2020;16:e1008312. [PMID: 32069329 DOI: 10.1371/journal.ppat.1008312] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Hasankhani A, Bahrami A, Mackie S, Maghsoodi S, Alawamleh HSK, Sheybani N, Safarpoor Dehkordi F, Rajabi F, Javanmard G, Khadem H, Barkema HW, De Donato M. In-depth systems biological evaluation of bovine alveolar macrophages suggests novel insights into molecular mechanisms underlying Mycobacterium bovis infection. Front Microbiol 2022;13. [DOI: 10.3389/fmicb.2022.1041314] [Reference Citation Analysis]
2 Salina EG, Makarov V. Mycobacterium tuberculosis Dormancy: How to Fight a Hidden Danger. Microorganisms 2022;10:2334. [DOI: 10.3390/microorganisms10122334] [Reference Citation Analysis]
3 Simper JD, Perez E, Schlesinger LS, Azad AK. Resistance and Susceptibility Immune Factors at Play during Mycobacterium tuberculosis Infection of Macrophages. Pathogens 2022;11. [PMID: 36297211 DOI: 10.3390/pathogens11101153] [Reference Citation Analysis]
4 Ganesan N, Ronsmans S, Vanoirbeek J, Hoet PHM. Assessment of Experimental Techniques That Facilitate Human Granuloma Formation in an In Vitro System: A Systematic Review. Cells 2022;11:864. [DOI: 10.3390/cells11050864] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Dalgic N, Sahin A, Torun SH, Kaba O, Onal P, Yilmaz AT, Turel O, Yasar B, Kara M, Aygun D, Kilinc A, Oncel S, Duramaz BB, Urganci N, Somer A, Cokugras H, Arisoy ES. Active and Latent Tuberculosis in Children Treated with Anti-TNF-α: A Retrospective Multicenter Study. J Pediatr Infect Dis. [DOI: 10.1055/s-0042-1743195] [Reference Citation Analysis]
6 Arbués A, Schmidiger S, Kammüller M, Portevin D. Extracellular Matrix-Induced GM-CSF and Hypoxia Promote Immune Control of Mycobacterium tuberculosis in Human In Vitro Granulomas. Front Immunol 2021;12:727508. [PMID: 34603299 DOI: 10.3389/fimmu.2021.727508] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Alvarez AH. Revisiting tuberculosis screening: An insight to complementary diagnosis and prospective molecular approaches for the recognition of the dormant TB infection in human and cattle hosts. Microbiol Res 2021;252:126853. [PMID: 34536677 DOI: 10.1016/j.micres.2021.126853] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 D'Arcy ME, Beachler DC, Pfeiffer RM, Curtis JR, Mariette X, Seror R, Mahale P, Rivera DR, Yanik EL, Engels EA. Tumor Necrosis Factor Inhibitors and the Risk of Cancer among Older Americans with Rheumatoid Arthritis. Cancer Epidemiol Biomarkers Prev 2021;30:2059-67. [PMID: 34426413 DOI: 10.1158/1055-9965.EPI-21-0125] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Park HE, Lee W, Shin MK, Shin SJ. Understanding the Reciprocal Interplay Between Antibiotics and Host Immune System: How Can We Improve the Anti-Mycobacterial Activity of Current Drugs to Better Control Tuberculosis? Front Immunol 2021;12:703060. [PMID: 34262571 DOI: 10.3389/fimmu.2021.703060] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Maizels RM. The multi-faceted roles of TGF-β in regulation of immunity to infection. Adv Immunol 2021;150:1-42. [PMID: 34176558 DOI: 10.1016/bs.ai.2021.05.001] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
11 Robert M, Miossec P. Reactivation of latent tuberculosis with TNF inhibitors: critical role of the beta 2 chain of the IL-12 receptor. Cell Mol Immunol 2021;18:1644-51. [PMID: 34021269 DOI: 10.1038/s41423-021-00694-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
12 Krug S, Parveen S, Bishai WR. Host-Directed Therapies: Modulating Inflammation to Treat Tuberculosis. Front Immunol 2021;12:660916. [PMID: 33953722 DOI: 10.3389/fimmu.2021.660916] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 15.0] [Reference Citation Analysis]
13 Lee C, Bhakta S. The Prospect of Repurposing Immunomodulatory Drugs for Adjunctive Chemotherapy against Tuberculosis: A Critical Review. Antibiotics (Basel) 2021;10:91. [PMID: 33477812 DOI: 10.3390/antibiotics10010091] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
14 Tezera LB, Reichmann MT, Al Shammari B, Elkington PT. In Vitro Models of Human Granuloma Formation to Analyze Host-Directed Therapies. Advances in Host-Directed Therapies Against Tuberculosis 2021. [DOI: 10.1007/978-3-030-56905-1_17] [Reference Citation Analysis]
15 Madhavan P, Rizwan F, Shaik I. Immuno-Pathogenesis of Respiratory Diseases. Medicinal Plants for Lung Diseases 2021. [DOI: 10.1007/978-981-33-6850-7_1] [Reference Citation Analysis]
16 Arbués A, Kammüller M, Portevin D. Generating Three-dimensional Human Granulomas in vitro to Study Mycobacterium tuberculosis-Host Interaction. Bio Protoc 2020;10:e3820. [PMID: 33659472 DOI: 10.21769/BioProtoc.3820] [Reference Citation Analysis]
17 Cantini F, Blandizzi C, Niccoli L, Petrone L, Goletti D. Systematic review on tuberculosis risk in patients with rheumatoid arthritis receiving inhibitors of Janus Kinases. Expert Opin Drug Saf 2020;19:861-72. [PMID: 32552289 DOI: 10.1080/14740338.2020.1774550] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]